en
Scientific article
English

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Published inAnnals of the rheumatic diseases, vol. 75, no. 7, p. 1336-1342
Publication date2016
Abstract

To examine the effectiveness of tocilizumab (TCZ) with and without synthetic disease-modifying antirheumatic drugs (sDMARDs) in a large observational study.

Citation (ISO format)
GABAY, Cem et al. Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study. In: Annals of the rheumatic diseases, 2016, vol. 75, n° 7, p. 1336–1342. doi: 10.1136/annrheumdis-2015-207760
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0003-4967
450views
0downloads

Technical informations

Creation08/31/2016 4:50:00 PM
First validation08/31/2016 4:50:00 PM
Update time03/15/2023 12:53:50 AM
Status update03/15/2023 12:53:49 AM
Last indexation01/16/2024 10:10:46 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack